Literature DB >> 28973891

Complement-activation fragment C4a mediates effector functions by binding as untethered agonist to protease-activated receptors 1 and 4.

HongBin Wang1, Daniel Ricklin2,3, John D Lambris2.   

Abstract

C4a is a small protein released from complement component C4 upon activation of the complement system's classical and lectin pathways, which are important constituents of innate immune surveillance. Despite the structural similarity between C4a and well-described anaphylatoxins C3a and C5a, the binding partner and biological function of C4a have remained elusive. Using a cell-based reporter assay, we screened C4a against a panel of both known and orphan G protein-coupled receptors and now provide evidence that C4a is a ligand for protease-activated receptor (PAR)1 and PAR4. Whereas C4a showed no activity toward known anaphylatoxin receptors, it acted as an agonist for both PAR1 and PAR4 with nanomolar activity. In human endothelial cells, ERK activation by C4a was mediated through both PAR1 and PAR4 in a Gαi-independent signaling pathway. Like other PAR1 activators, C4a induced calcium mobilization through the PAR1/Gαq/PLCβ signaling axis. Moreover, C4a increased stress fiber formation and enhanced endothelial permeability, both of which were reduced by PAR1 antagonists. In sum, our study identifies C4a as an untethered agonist for PAR1 and PAR4 with effects on cellular activation and endothelial permeability, thereby revealing another instance of cross-talk between the complement system and other host defense pathways.

Entities:  

Keywords:  C4a; PAR1; PAR4; complement; endothelial cells

Mesh:

Substances:

Year:  2017        PMID: 28973891      PMCID: PMC5642699          DOI: 10.1073/pnas.1707364114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

1.  Differential expression of protease-activated receptors 1, 2, and 4 on human endothelial cells from different vascular sites.

Authors:  Masakazu Fujiwara; Enjing Jin; Mohammad Ghazizadeh; Oichi Kawanami
Journal:  Pathobiology       Date:  2004       Impact factor: 4.342

2.  Domains specifying thrombin-receptor interaction.

Authors:  T K Vu; V I Wheaton; D T Hung; I Charo; S R Coughlin
Journal:  Nature       Date:  1991-10-17       Impact factor: 49.962

3.  C5a induces tissue factor activity on endothelial cells.

Authors:  K Ikeda; K Nagasawa; T Horiuchi; T Tsuru; H Nishizaka; Y Niho
Journal:  Thromb Haemost       Date:  1997-02       Impact factor: 5.249

4.  G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells.

Authors:  C Tiruppathi; W Yan; R Sandoval; T Naqvi; A N Pronin; J L Benovic; A B Malik
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

Review 5.  Multiple roles of complement MASP-1 at the interface of innate immune response and coagulation.

Authors:  József Dobó; Verena Schroeder; Lorenz Jenny; László Cervenak; Péter Závodszky; Péter Gál
Journal:  Mol Immunol       Date:  2014-06-14       Impact factor: 4.407

6.  The ligand occupancy of endothelial protein C receptor switches the protease-activated receptor 1-dependent signaling specificity of thrombin from a permeability-enhancing to a barrier-protective response in endothelial cells.

Authors:  Jong-Sup Bae; Likui Yang; Chandrashekhara Manithody; Alireza R Rezaie
Journal:  Blood       Date:  2007-09-06       Impact factor: 22.113

7.  Protease-activated receptors 1 and 4 mediate thrombin signaling in endothelial cells.

Authors:  Hiroshi Kataoka; Justin R Hamilton; David D McKemy; Eric Camerer; Yao-Wu Zheng; Abby Cheng; Courtney Griffin; Shaun R Coughlin
Journal:  Blood       Date:  2003-07-17       Impact factor: 22.113

8.  C4a: the third anaphylatoxin of the human complement system.

Authors:  J P Gorski; T E Hugli; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

9.  The active site of human C4a anaphylatoxin.

Authors:  T E Hugli; M S Kawahara; C G Unson; R Molinar-Rode; B W Erickson
Journal:  Mol Immunol       Date:  1983-06       Impact factor: 4.407

10.  Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a.

Authors:  C Gerard; T E Hugli
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

View more
  42 in total

1.  Pneumonia: host susceptibility and shared genetics with pulmonary function and other traits.

Authors:  M B Khadzhieva; A N Kuzovlev; L E Salnikova
Journal:  Clin Exp Immunol       Date:  2019-10-01       Impact factor: 4.330

Review 2.  The complex functioning of the complement system in xenotransplantation.

Authors:  Hongmin Zhou; Hidetaka Hara; David K C Cooper
Journal:  Xenotransplantation       Date:  2019-04-29       Impact factor: 3.907

Review 3.  The role of complement in antibody mediated transplant rejection.

Authors:  Joshua M Thurman; Sarah E Panzer; Moglie Le Quintrec
Journal:  Mol Immunol       Date:  2019-06-10       Impact factor: 4.407

4.  Bothrops lanceolatus snake (Fer-de-lance) venom triggers inflammatory mediators' storm in human blood.

Authors:  Felipe Silva de França; Joel José Megale Gabrili; Laurence Mathieu; François Burgher; Joël Blomet; Denise V Tambourgi
Journal:  Arch Toxicol       Date:  2021-01-04       Impact factor: 5.153

Review 5.  Targeting complement-mediated immunoregulation for cancer immunotherapy.

Authors:  Martin Kolev; Maciej M Markiewski
Journal:  Semin Immunol       Date:  2018-02-15       Impact factor: 11.130

Review 6.  The renaissance of complement therapeutics.

Authors:  Daniel Ricklin; Dimitrios C Mastellos; Edimara S Reis; John D Lambris
Journal:  Nat Rev Nephrol       Date:  2017-12-04       Impact factor: 28.314

Review 7.  New insights into the immune functions of complement.

Authors:  Edimara S Reis; Dimitrios C Mastellos; George Hajishengallis; John D Lambris
Journal:  Nat Rev Immunol       Date:  2019-08       Impact factor: 53.106

Review 8.  More than a Pore: Nonlytic Antimicrobial Functions of Complement and Bacterial Strategies for Evasion.

Authors:  Elisabet Bjanes; Victor Nizet
Journal:  Microbiol Mol Biol Rev       Date:  2021-01-27       Impact factor: 11.056

9.  The complement cascade in Alzheimer's disease: a systematic review and meta-analysis.

Authors:  Saffire H Krance; Che-Yuan Wu; Yi Zou; Huiyan Mao; Sina Toufighi; Xueyin He; Maureen Pakosh; Walter Swardfager
Journal:  Mol Psychiatry       Date:  2019-10-18       Impact factor: 15.992

10.  Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics.

Authors:  Peter Garred; Andrea J Tenner; Tom E Mollnes
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.